Linked Life Data

15497172

Source:http://linkedlifedata.com/resource/pubmed/id/15497172

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-10-21
pubmed:abstractText
The spectrum of acute lower respiratory tract infection ranges from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Annually approximately five million people die of acute respiratory tract infections. Among these, pneumonia represents the most frequent cause of mortality, hospitalization and medical consultation. Azithromycin is a new macrolide antibiotic, structurally modified from erythromycin and is noted for its activity against some gram-negative organisms associated with respiratory tract infections, particularly Haemophilus influenzae (H. influenzae).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD001954
pubmed:dateRevised
2008-4-14
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Azithromycin for acute lower respiratory tract infections.
pubmed:affiliation
Community Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Road, Chiang Mai, Thailand, 50200.
pubmed:publicationType
Journal Article, Review, Meta-Analysis